Stay updated on CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Sign up to get notified when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.

Latest updates to the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ALS trial record is available with its study overview, eligibility criteria, 64 locations, treatment arms, outcome measures, publications, and record dates. The previous 403 error view is replaced by the study details.SummaryDifference85%

- Check19 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check26 days agoChange DetectedA banner announces an NIH website terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s revision label changed from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe 403 Forbidden page HTML and related navigation were removed, indicating the page is no longer in an error state and may render the study details.SummaryDifference0.5%

Stay in the know with updates to CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CK-2127107 in ALS: FORTITUDE-ALS Clinical Trial page.